Related Experiment Video

Updated: Apr 16, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.3K

miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer

Anil Belur Nagaraj1, Peronne Joseph, Analisa DiFeo

  • 1Case Comprehensive Cancer Center, Case Western Reserve University, 2103 Cornell Road, Cleveland, OH 44106, USA.

Biomarkers in Medicine
|March 4, 2015
PubMed

Insights

MicroRNAs (miRNAs) show promise in overcoming chemotherapy resistance in epithelial ovarian cancer (EOC). Modulating these molecules could improve treatment efficacy for advanced EOC patients.

Area of Science:

  • Gynecologic Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Epithelial ovarian cancer (EOC) is a leading cause of cancer death in women.
  • Drug resistance significantly impacts survival rates in advanced EOC.
  • Targeting regulatory molecules is crucial for developing effective adjuvant therapies.

Purpose of the Study:

  • To review the role of microRNAs (miRNAs) in regulating EOC.
  • To highlight the prognostic and therapeutic significance of miRNAs in EOC.
  • To explore miRNA modulation as a strategy to enhance chemotherapy efficacy.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of miRNA functions in EOC chemoresistance.
  • Discussion of miRNA-based therapeutic strategies.

Main Results:

  • miRNAs play a key role in regulating the chemoresistant phenotype in EOC.
  • Specific miRNAs can serve as prognostic biomarkers for EOC.
  • miRNA modulation offers a potential approach to overcome drug resistance.

Conclusions:

  • miRNAs are critical regulators of EOC biology and chemoresistance.
  • Targeting miRNAs presents a promising avenue for novel EOC therapies.
  • miRNA-based strategies could improve chemotherapy outcomes in EOC.
Keywords:
MRX34OncomiRsbiomarkerschemotherapy resistanceepithelial ovarian cancermiRNA expression profilingmiRNAspharmaco-miRtumor heterogeneitytumor suppressor miRs

More Related Videos

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

525
A Proximal Culture Method to Study Paracrine Signaling Between Cells08:17

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

10.2K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.9K